Verpoest W, De Rademaeker M, Sermon K, De Rycke M, Seneca S, Papanikolaou E, Spits C, Van Landuyt L, Van der Elst J, Haentjens P, Devroey P, Liebaers I
Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, UZ Brussel, 101 Laarbeeklaan, B-1090 Brussel, Belgium.
Hum Reprod. 2008 Jul;23(7):1654-60. doi: 10.1093/humrep/den105. Epub 2008 Apr 12.
This study aimed to analyse the reproductive outcome of a large cohort of myotonic dystrophy type 1 (DM1) patients undergoing ICSI and PGD. The secondary outcome parameter of this study was ovarian response as a way to express gonadal function in female DM1 patients.
Prospective cohort study. Real and expected cumulative delivery rates are descriptive. The reproductive outcome per cycle was compared with that of a control group of patients with X-linked recessive disorders. The comparative analysis of ovarian stimulation parameters in the study group versus the control group was carried out using both bivariate (crude) and multivariate (linear regression) analysis.
Between 1995 and 2005, 205 cycles of ICSI and PGD were carried out for DM1 in 78 couples. The real cumulative delivery rate (max 6 cycles) overall was 46%. The expected overall cumulative delivery rate was 72%. Multivariate analysis did not show a significant difference in total dose of gonadotrophins used for ovarian stimulation between Group A (in which the female partner was affected) and a control group.
This study shows that ICSI and PGD for DM1 offer good reproductive outcome, both in cumulative terms and per treatment cycle. There is no evidence of impaired gonadal function in female DM1 patients.
本研究旨在分析一大群接受卵胞浆内单精子注射(ICSI)和植入前基因诊断(PGD)的1型强直性肌营养不良(DM1)患者的生殖结局。本研究的次要结局参数是卵巢反应,以此作为评估女性DM1患者性腺功能的一种方式。
前瞻性队列研究。实际和预期的累积分娩率为描述性指标。将每个周期的生殖结局与一组X连锁隐性疾病患者的对照组进行比较。使用双变量(粗)分析和多变量(线性回归)分析对研究组与对照组的卵巢刺激参数进行比较分析。
1995年至2005年期间,78对夫妇针对DM1进行了205个周期的ICSI和PGD。总体实际累积分娩率(最多6个周期)为46%。预期总体累积分娩率为72%。多变量分析未显示A组(女性伴侣受影响)与对照组在用于卵巢刺激的促性腺激素总剂量上存在显著差异。
本研究表明,针对DM1的ICSI和PGD在累积和每个治疗周期方面都提供了良好的生殖结局。没有证据表明女性DM1患者性腺功能受损。